Falk Sommer1, Eberhard Spörl2, Robert Herber2, Lutz E Pillunat2, Naim Terai2. 1. Department of Ophthalmology, Carl Gustav Carus Faculty of Medicine, Technical University, Fetscherstr. 74, 01307, Dresden, Germany. falk.sommer@uniklinikum-dresden.de. 2. Department of Ophthalmology, Carl Gustav Carus Faculty of Medicine, Technical University, Fetscherstr. 74, 01307, Dresden, Germany.
Abstract
PURPOSE: To investigate the impact of ocular symptom, non-ocular symptom, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and temporal artery ultrasound (TAU) findings on the predictive value of a positive temporal artery biopsy (TAB) in patients with clinically suspected giant cell arteritis (GCA). METHODS: In a retrospective, interventional study, data from 68 patients with clinically suspected GCA who underwent TAB between 2015 and 2017 were analysed. Analysis included five parameters: ocular symptom, non-ocular symptom, ESR, CRP level and TAU findings. Using a contingency table, each parameter was separately analysed for the predictive value of a positive TAB, and a discriminant analysis was applied to check for the predictive value of a positive TAB under consideration of all five parameters and of the three strongest predictive parameters. RESULTS: A positive TAB was significantly associated with a positive TAU in 15 of 15 patients (p < 0.001), an increased ESR in 37 of 53 patients (p < 0.001), an increased CRP level in 35 of 56 patients (p = 0.004) and non-ocular symptoms in 27 of 40 patients (p = 0.01). A positive TAB was not significantly associated with the presence of ocular symptoms (25 of 46 patients, p = 0.988). Using a discriminant analysis, the combined parameters TAU, ESR and CRP were able to predict a positive TAB in 97.3% of all patients. The positive predictive value was 78.3%, and the negative predictive value was 95.4%. CONCLUSION: Temporal artery biopsy to confirm the diagnosis of GCA may not be mandatory in patients who show an elevated ESR and CRP level and a positive TAU.
PURPOSE: To investigate the impact of ocular symptom, non-ocular symptom, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and temporal artery ultrasound (TAU) findings on the predictive value of a positive temporal artery biopsy (TAB) in patients with clinically suspected giant cell arteritis (GCA). METHODS: In a retrospective, interventional study, data from 68 patients with clinically suspected GCA who underwent TAB between 2015 and 2017 were analysed. Analysis included five parameters: ocular symptom, non-ocular symptom, ESR, CRP level and TAU findings. Using a contingency table, each parameter was separately analysed for the predictive value of a positive TAB, and a discriminant analysis was applied to check for the predictive value of a positive TAB under consideration of all five parameters and of the three strongest predictive parameters. RESULTS: A positive TAB was significantly associated with a positive TAU in 15 of 15 patients (p < 0.001), an increased ESR in 37 of 53 patients (p < 0.001), an increased CRP level in 35 of 56 patients (p = 0.004) and non-ocular symptoms in 27 of 40 patients (p = 0.01). A positive TAB was not significantly associated with the presence of ocular symptoms (25 of 46 patients, p = 0.988). Using a discriminant analysis, the combined parameters TAU, ESR and CRP were able to predict a positive TAB in 97.3% of all patients. The positive predictive value was 78.3%, and the negative predictive value was 95.4%. CONCLUSION: Temporal artery biopsy to confirm the diagnosis of GCA may not be mandatory in patients who show an elevated ESR and CRP level and a positive TAU.
Authors: Raashid Luqmani; Ellen Lee; Surjeet Singh; Mike Gillett; Wolfgang A Schmidt; Mike Bradburn; Bhaskar Dasgupta; Andreas P Diamantopoulos; Wulf Forrester-Barker; William Hamilton; Shauna Masters; Brendan McDonald; Eugene McNally; Colin Pease; Jennifer Piper; John Salmon; Allan Wailoo; Konrad Wolfe; Andrew Hutchings Journal: Health Technol Assess Date: 2016-11 Impact factor: 4.014
Authors: Miguel A Gonzalez-Gay; Sonia Barros; Maria J Lopez-Diaz; Carlos Garcia-Porrua; Amalia Sanchez-Andrade; Javier Llorca Journal: Medicine (Baltimore) Date: 2005-09 Impact factor: 1.889
Authors: Khoi Le; Lindsay M Bools; Allison B Lynn; Thomas V Clancy; W Borden Hooks; William W Hope Journal: Am J Surg Date: 2014-10-13 Impact factor: 2.565
Authors: Rachel Black; Denise Roach; Maureen Rischmueller; Susan L Lester; Catherine L Hill Journal: Int J Rheum Dis Date: 2013-06-08 Impact factor: 2.454
Authors: Alwin Sebastian; Fiona Coath; Sue Innes; Jo Jackson; Kornelis S M van der Geest; Bhaskar Dasgupta Journal: Rheumatol Adv Pract Date: 2021-08-19
Authors: Kornelis S M van der Geest; Maria Sandovici; Elisabeth Brouwer; Sarah L Mackie Journal: JAMA Intern Med Date: 2020-10-01 Impact factor: 21.873